ir.cantabio.com ir.cantabio.com

ir.cantabio.com

Investor Relations :: Cantabio Pharmaceuticals Inc. (CTBO)

Engineered CNS-penetrant DJ-1 Protein. Cantabio in the News. Neurodegeneration in the News. Cantabio Pharmaceuticals to Present at the 9th Annual Biotech Showcase in San Francisco. Dec 15, 2016. Ended Sep 30, 2015. Toll Free helpline: (844) 200-CTBO. Cantabio Pharmaceuticals is listed in Mergent Manuals and News Reports and the company’s data, as well as news and financial statements, are accessible via Mergent’s online and print products. The Mergent Industrial Manual and News Reports is a recognize...

http://ir.cantabio.com/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR IR.CANTABIO.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

March

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Tuesday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 1.7 out of 5 with 3 reviews
5 star
0
4 star
0
3 star
1
2 star
0
1 star
2

Hey there! Start your review of ir.cantabio.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

0.2 seconds

FAVICON PREVIEW

  • ir.cantabio.com

    16x16

  • ir.cantabio.com

    32x32

  • ir.cantabio.com

    64x64

  • ir.cantabio.com

    128x128

CONTACTS AT IR.CANTABIO.COM

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

CONTENT

SCORE

6.2

PAGE TITLE
Investor Relations :: Cantabio Pharmaceuticals Inc. (CTBO) | ir.cantabio.com Reviews
<META>
DESCRIPTION
Engineered CNS-penetrant DJ-1 Protein. Cantabio in the News. Neurodegeneration in the News. Cantabio Pharmaceuticals to Present at the 9th Annual Biotech Showcase in San Francisco. Dec 15, 2016. Ended Sep 30, 2015. Toll Free helpline: (844) 200-CTBO. Cantabio Pharmaceuticals is listed in Mergent Manuals and News Reports and the company’s data, as well as news and financial statements, are accessible via Mergent’s online and print products. The Mergent Industrial Manual and News Reports is a recognize...
<META>
KEYWORDS
1 overview
2 market need
3 management team
4 board of directors
5 scientific advisors
6 scientific leads
7 awarded grants
8 cantabio's team
9 scientific approach
10 pipeline
CONTENT
Page content here
KEYWORDS ON
PAGE
overview,market need,management team,board of directors,scientific advisors,scientific leads,awarded grants,cantabio's team,scientific approach,pipeline,therapeutic targets,dj 1 pharmacological chaperones,tau pharmacological chaperone,publications,html
SERVER
Apache
CONTENT-TYPE
utf-8
GOOGLE PREVIEW

Investor Relations :: Cantabio Pharmaceuticals Inc. (CTBO) | ir.cantabio.com Reviews

https://ir.cantabio.com

Engineered CNS-penetrant DJ-1 Protein. Cantabio in the News. Neurodegeneration in the News. Cantabio Pharmaceuticals to Present at the 9th Annual Biotech Showcase in San Francisco. Dec 15, 2016. Ended Sep 30, 2015. Toll Free helpline: (844) 200-CTBO. Cantabio Pharmaceuticals is listed in Mergent Manuals and News Reports and the company’s data, as well as news and financial statements, are accessible via Mergent’s online and print products. The Mergent Industrial Manual and News Reports is a recognize...

INTERNAL PAGES

ir.cantabio.com ir.cantabio.com
1

form10-q.htm

http://ir.cantabio.com/all-sec-filings/content/0001424884-15-000177/form10-q.htm

SECURITIES AND EXCHANGE COMMISSION. Washington, D.C. 20549. QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended September 30, 2015. TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the transition period from    to . Commission File Number: 000-54905. Exact name of registrant as specified in its charter). State or other jurisdiction of incorporation). IRS Employer Identification No.). Indicate by che...

2

Cantabio Pharmaceuticals to Present at the 9th Annual Biotech Showcase in San Francisco :: Cantabio Pharmaceuticals Inc. (CTBO)

http://ir.cantabio.com/press-releases/detail/16/cantabio-pharmaceuticals-to-present-at-the-9th-annual

Engineered CNS-penetrant DJ-1 Protein. Cantabio in the News. Neurodegeneration in the News. Cantabio Pharmaceuticals to Present at the 9th. Cantabio Pharmaceuticals to Present at the 9th Annual Biotech Showcase in San Francisco. December 15, 2016. SAN FRANCISCO, CA - (Marketwired) - 12/15/16 - Cantabio Pharmaceuticals, Inc. (OTCQB: CTBO). Annual Biotech Showcase on January 10. About Cantabio Pharmaceuticals, Inc. Cantabio is focused on bringing novel, first-in-class drug candidates into clinical trials a...

3

form10-qa.htm

http://ir.cantabio.com/all-sec-filings/content/0001424884-15-000179/form10-qa.htm

SECURITIES AND EXCHANGE COMMISSION. Washington, D.C. 20549. Amendment No. 1. QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended September 30, 2015. TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the transition period from    to . Commission File Number: 000-54905. Exact name of registrant as specified in its charter). State or other jurisdiction of incorporation). 2225 East Bayshore Road #223.

4

Email Alerts :: Cantabio Pharmaceuticals Inc. (CTBO)

http://ir.cantabio.com/email-alerts

Engineered CNS-penetrant DJ-1 Protein. Cantabio in the News. Neurodegeneration in the News. Please fill out the form below to receive company press releases via email when they occur. Annual & Quarterly Reports. We respect your privacy. We do not sell, rent, or loan any information to any third party. Any information you give us is held with the utmost care and security, and will be used only in ways to which you have consented. Sign up for email updates. Be the first to receive breaking news.

UPGRADE TO PREMIUM TO VIEW 0 MORE

TOTAL PAGES IN THIS WEBSITE

4

LINKS TO THIS WEBSITE

cantabio.com cantabio.com

Parkinson’s Disease :: Cantabio Pharmaceuticals Inc. (CTBO)

http://www.cantabio.com/neurodegenerative-diseases/parkinsons-disease

Engineered CNS-penetrant DJ-1 Protein. Cantabio in the News. Neurodegeneration in the News. There are 1 million living with Parkinson's in the USA. 60,000 Americans are diagnosed with Parkinson's disease each year, and this number does not reflect the thousands of cases that go undetected. The combined direct and indirect cost of Parkinson's, including treatment, social security payments and lost income from inability to work, is estimated to be nearly $25 billion per year. Feb 14, 2017.

cantabio.com cantabio.com

Locations :: Cantabio Pharmaceuticals Inc. (CTBO)

http://www.cantabio.com/locations

Engineered CNS-penetrant DJ-1 Protein. Cantabio in the News. Neurodegeneration in the News. Sunnyvale, CA 94085-4037. 1117 Budapest, Magyar tudósok körútja 2. Feb 14, 2017. Cantabio Pharmaceuticals to Present Results from Its Tau Protein Targeting Therapeutic Program for the Treatment of Alzheimer's Disease at the 13th International Conference on Alzheimer's and Parkinson's Disease. Sign up for email updates. Be the first to receive breaking news. 2017 Cantabio Pharmaceuticals Inc.

cantabio.com cantabio.com

Cantabio in the News :: Cantabio Pharmaceuticals Inc. (CTBO)

http://www.cantabio.com/news-media/cantabio-in-the-news

Engineered CNS-penetrant DJ-1 Protein. Cantabio in the News. Neurodegeneration in the News. Cantabio in the News. Cantabio in the News. Neurodegeneration in the News. Cantabio in the News. October 20, 2016. Pursuing Novel Treatment Strategies for Neurodegenerative Diseases. September 23, 2016. Interview with Dr. Gergely Tóth (founder and CEO), Dr. Thomas Sawyer (COO) regarding Cantabio's research and its preclinical development programs published in U.S. Pharma Newsletter. Sign up for email updates.

cantabio.com cantabio.com

Press Releases :: Cantabio Pharmaceuticals Inc. (CTBO)

http://www.cantabio.com/news-media

Engineered CNS-penetrant DJ-1 Protein. Cantabio in the News. Neurodegeneration in the News. Cantabio in the News. Neurodegeneration in the News. Cantabio Pharmaceuticals to Present Results from Its Tau Protein Targeting Therapeutic Program for the Treatment of Alzheimer's Disease at the 13th International Conference on Alzheimer's and Parkinson's Disease. February 14, 2017. Cantabio Pharmaceuticals announces Definitive Funding Agreement of up to $600,000 from Yorkville Advisors Global. February 2, 2017.

cantabio.com cantabio.com

Engineered CNS-penetrant DJ-1 Protein :: Cantabio Pharmaceuticals Inc. (CTBO)

http://www.cantabio.com/scientific-approach/engineered-cns-penetrant-dj-1-protein

Engineered CNS-penetrant DJ-1 Protein. Cantabio in the News. Neurodegeneration in the News. Engineered CNS-penetrant DJ-1 Protein. Engineered CNS-penetrant DJ-1 Protein. Engineered CNS-penetrant DJ-1 Protein. Molecule CB201 - PARKINSON’S DISEASE. Sign up for email updates. Be the first to receive breaking news. 2017 Cantabio Pharmaceuticals Inc.

cantabio.com cantabio.com

Social Media :: Cantabio Pharmaceuticals Inc. (CTBO)

http://www.cantabio.com/news-media/social-media

Engineered CNS-penetrant DJ-1 Protein. Cantabio in the News. Neurodegeneration in the News. Cantabio in the News. Neurodegeneration in the News. Sign up for email updates. Be the first to receive breaking news. 2017 Cantabio Pharmaceuticals Inc.

cantabio.com cantabio.com

Overview :: Cantabio Pharmaceuticals Inc. (CTBO)

http://www.cantabio.com/scientific-approach/overview

Engineered CNS-penetrant DJ-1 Protein. Cantabio in the News. Neurodegeneration in the News. Engineered CNS-penetrant DJ-1 Protein. Cantabio’s ability to generate a pipeline of high quality therapeutic candidates stems from its integration of key elements and novel discovery techniques, combined with years of experience in the field. Cantabio strategically integrates therapeutic focus, target family biophysics, novel drug discovery technologies and expertise into an innovative drug discovery app...Covalen...

cantabio.com cantabio.com

Press Releases :: Cantabio Pharmaceuticals Inc. (CTBO)

http://www.cantabio.com/news-media/press-releases

Engineered CNS-penetrant DJ-1 Protein. Cantabio in the News. Neurodegeneration in the News. Cantabio in the News. Neurodegeneration in the News. Cantabio Pharmaceuticals to Present Results from Its Tau Protein Targeting Therapeutic Program for the Treatment of Alzheimer's Disease at the 13th International Conference on Alzheimer's and Parkinson's Disease. February 14, 2017. Cantabio Pharmaceuticals announces Definitive Funding Agreement of up to $600,000 from Yorkville Advisors Global. February 2, 2017.

cantabio.com cantabio.com

Partnerships :: Cantabio Pharmaceuticals Inc. (CTBO)

http://www.cantabio.com/partnerships

Engineered CNS-penetrant DJ-1 Protein. Cantabio in the News. Neurodegeneration in the News. Cutting-edge commercial research requires collaboration between global research groups and companies. Cantabio pharmaceuticals’network of collaborators combine to produce a powerful strategic research advantage. NovAlix - our industrial partner in a number of research applications spanning from high throughput screening to x-ray crystallography. Feb 14, 2017. Cantabio Pharmaceuticals Inc. conducts novel and in...

UPGRADE TO PREMIUM TO VIEW 32 MORE

TOTAL LINKS TO THIS WEBSITE

41

OTHER SITES

ir.callon.com ir.callon.com

Investor Overview | Callon Petroleum

Health, Environment and Safety. Sunday, August 16, 2015. Health, Environment and Safety. Founded in 1950, Callon is an independent energy company focused on the acquisition, development, exploration, and operation of oil and gas properties in the Permian Basin in West Texas. Aug 5, 2015. Callon Petroleum Company Announces Second Quarter 2015 Results and Increases Annual Production Guidance. Aug 3, 2015. Callon Petroleum Company Announces Upcoming Investor Event. Jul 9, 2015. Jun 10, 2015.

ir.calpoly.edu ir.calpoly.edu

IR Home - Institutional Research - Cal Poly, San Luis Obispo

Overview of Publications and Reports. The scope of the Office of Institutional Research includes:. Providing aggregate data to support campus planning and analysis. Support for strategic planning, assessment, program review, and accreditation. Our publications require the Adobe Acrobat PDF Reader. Visit the Adobe website to download a FREE copy of Adobe Reader now! CONNECT WITH CAL POLY. Campus Maps and Directions. 169; 2015 California Polytechnic State University. San Luis Obispo, California 93407.

ir.calstatela.edu ir.calstatela.edu

CSULA | Institutional Research

Skip to the content. Skip to the footer. The Office of Institutional Research. Admin 710 (323) 343 - 2730 FAX: (323) 343 - 2746. Fall 14 Fact Sheet. Fall 13 Fact Sheet. Fall 12 Fact Sheet. Fall 2012 - #53. Fall 2010 - #51. Fall 2009 - #49. FTES, FTEF and SFR. AY 2014 - 2015. AY 2013 - 2014. AY 2012 - 2013. AY 2011 - 2012. National Study of Student Engagement (NSSE). 2014 High Impact Practices. 2014 Engagement Indicator Practices. Program Planning Data Site. Program Planning Data Site. Institutional Resea...

ir.calwatergroup.com ir.calwatergroup.com

California Water Service Group: Investor Relations

Our purpose is to enhance the quality of life for our customers, communities, employees, and stockholders. Hawaii Water Service Company. New Mexico Water Service Company. Washington Water Service Company. Home Emergency Insurance Solutions (HEIS). Investor Overview and Company Profile. Reports and SEC Filings. Hawaii Water Service Company. New Mexico Water Service Company. Washington Water Service Company. Home Emergency Insurance Solutions (HEIS). Investor Overview and Company Profile.

ir.cambrex.com ir.cambrex.com

Shareholder Information | Cambrex | APIs for Small Molecule Therapeutics

Q2 2015 Cambrex Earnings Conference Call. Thursday, July 30, 2015 8:00 am ET. Cambrex at Jefferies 2015 Global Healthcare Conference. Wednesday, June 3, 2015 8:00 am ET. 160; Jefferies 2015 Global Healthcare Conference Presentation. Cambrex Corporation is a custom development and manufacturing organization that specializes in products and services that accelerate the development and commercialization of small molecule therapeutics. 160; 0.32. Data as of 08/07/15 4:00 pm ET. Minimum 20 minute delay. Repli...

ir.cantabio.com ir.cantabio.com

Investor Relations :: Cantabio Pharmaceuticals Inc. (CTBO)

Engineered CNS-penetrant DJ-1 Protein. Cantabio in the News. Neurodegeneration in the News. Cantabio Pharmaceuticals to Present at the 9th Annual Biotech Showcase in San Francisco. Dec 15, 2016. Ended Sep 30, 2015. Toll Free helpline: (844) 200-CTBO. Cantabio Pharmaceuticals is listed in Mergent Manuals and News Reports and the company’s data, as well as news and financial statements, are accessible via Mergent’s online and print products. The Mergent Industrial Manual and News Reports is a recognize...

ir.canterbury.ac.nz ir.canterbury.ac.nz

UC Research Repository

JavaScript is disabled for your browser. Some features of this site may not work without it. All of the Repository. Chase, J.G. (591). Shaw, G.M. (299). Dhakal, R.P. (164). Hann, C.E. (164). Bradley, B.A. (140). Desaive, T. (117). Pampanin, S. (99). Billinghurst, M. (95). Mitrovic, A. (92). Cubrinovski, M. (91). 290000 Engineering and Technology (1123). 09 - Engineering (1057). 11 - Medical and Health Sciences (459). 01 - Mathematical Sciences (388). 13 - Education (361). 2000 - 2018 (11646). Horizontal ...

ir.cantonhermidas.com ir.cantonhermidas.com

صندوق سرمایه گذاری، سرمایه گذاری خصوصی، مدیریت اموال و دارایی و تأمین مالی - کانتون هرمیداس

مدیریت اموال و دارایی. معادن و منابع طبیعی. هتل داری و گردشگری. استارتاپ، تکنولوژی و نوآوری. خدمات مالی و صندوق ها. صندوق های تامین سرمایه. صندوق های سرمایه و تأمین نیازمندیهای مالی. سرمایه گذاری خصوصی و و نچر ک پیتال. سرمایه گذاری سهامی در شرکت ها و پروژه ها در صنایع و فن آوری ها و مدیریت سرمایه جهت رشد و توسعه فعالیت های اقتصادی. سرمایه گذاری در بازارهای املاک و مستغلات. سرمایه گذاری در بازارهای املاک و مستغلات بین المللی و افزودن ارزش از طریق توسعه و مدیریت پروژه ها. 7 November, 2013.

ir.cantor.com ir.cantor.com

Cantor Fitzgerald - CFLP Bondholders

Press Releases and Media Coverage. Enter the code shown above. Complete a Certification Form. Powered By Q4 Inc.

ir.capfed.com ir.capfed.com

Capitol Federal Investor Relations - Corporate Profile

News and Market Data. As of August 7, 2015 -. Minimum 20 minute delay. Capitol Federal Financial, Inc. Capitol Federal Financial, Inc. Reports Third Quarter Fiscal Year 2015 Results. Capitol Federal Financial, Inc. Announces Quarterly Dividend. Capitol Federal Financial, Inc. Announces True Blue Capitol Dividend. Capitol Federal Financial, Inc. Reports Second Quarter Fiscal Year 2015 Results. Capitol Federal Financial, Inc. Announces Quarterly Dividend. Capitol Federal Financial, Inc. 700 S Kansas Ave.

ir.capitalpplp.com ir.capitalpplp.com

Capital Product Partners L.P. - Company Overview

Ice Conditions on Board. Unit Distributions Tax Treatment. IRC Section 6045B Reporting. 325 - 0.00. Stock info ». Quotes delayed at least 20 minutes. Information provided by eSignal. Marketcap reflects previous day. 2016 Annual Meeting Materials. Last updated: November 10, 2016). News / Recent Press Releases. Capital Product Partners L.P. Schedules Third Quarter 2016 Earnings Release, Conference Call and Webcast. View all ». Capital Product Partners L.P. Investor Presentation. View all ».